Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

PEI-CL/OVA nanovaccine

Based on

9 Articles
2017 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(iminoethylene)

polyethyleneimine polyaziridine PEI
Type Polymer
Formula
Role carriers
2

ovalbumin

OVA
Type Biomolecule
Formula
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
Zeta potential

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information/entries available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
Balb/c mouse

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
  1. L9gM3mgbBqSBEMVH
  2. Kuv1Jm
Product

PEI-CL/OVA nanovaccine

Size: not specified

Medium/Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  1. FTcGO65jMVwAXuL
  2. i7Ec0j
Product

PEI-CL/OVA nanovaccine

Size: not specified

Medium: saline

Support: none

Method 3

Type: Physical formation
Source:
Product

PEI-CL/OVA nanovaccine

Diameter: 338.7 - 344.5 nm

Hydrodynamic diameter: 586.29 - 595.31 nm

Medium: water

Support: none

Method 4

Type: Physical formation
Source:
Starting materials
  • poly(lactic-co-glycolic acid)
  1. aIabEPtMx7kFo
Product

PEI-CL/OVA nanovaccine

Diameter: 338.7 - 344.5 nm

Medium/Support: none

Method 5

Type: Physical formation
Source:
  1. gaBKbrwBWToa2gxQ
  2. nKWsIh
Product

PEI-CL/OVA nanovaccine

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial